[HTML][HTML] Application of blood-based biomarkers of Alzheimer's disease in clinical practice: Recommendations from Taiwan Dementia Society
YW Cheng, YJ Lin, YS Lin, WP Hong, YC Kuan… - Journal of the Formosan …, 2024 - Elsevier
Blood-based biomarkers (BBM) are potentially powerful tools that assist in the biological
diagnosis of Alzheimer's disease (AD) in vivo with minimal invasiveness, relatively low cost …
diagnosis of Alzheimer's disease (AD) in vivo with minimal invasiveness, relatively low cost …
Tau induces inflammasome activation and microgliosis through acetylating NLRP3
L Zhang, Y Gai, Y Liu, D Meng, Y Zeng… - Clinical and …, 2024 - Wiley Online Library
Background Alzheimer's disease (AD) and related Tauopathies are characterised by the
pathologically hyperphosphorylated and aggregated microtubule‐associated protein Tau …
pathologically hyperphosphorylated and aggregated microtubule‐associated protein Tau …
Non-invasive Brain Stimulation Enhance the Physical Exercise Effect Against the Cognition Impairments and Dementia Symptoms in Alzheimer's Disease: A …
V Furtado-da-Silva, CJ Borges, I de Aquino Freire… - 2024 - preprints.org
Background: Alzheimer's Disease (AD) is a progressive and incurable condition that
prompts the exploration of interventions to slow its advancement and enhance the quality of …
prompts the exploration of interventions to slow its advancement and enhance the quality of …
[PDF][PDF] STUDY ON BLOOD PROTEIN MARKERS OFALZHEIMER'S
F Gonon - 2024 - upubscience.com
Alzheimer's disease (AD) is a common degenerative disease of the central nervous system,
and early diagnosis is very important for its treatment. However, clinical diagnosis currently …
and early diagnosis is very important for its treatment. However, clinical diagnosis currently …